Grants per year
- 1 - 25 out of 303 results
Search results
-
Active
Prot #GA45331: A Phase III, Multicenter, Double-Blind, Placebo-Controlled, Treat-Through Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy with RO7790121 in Patients with Moderately to Severely Active Crohn’s Disease
Dulai, P. S. (PD/PI)
ICON Clinical Research, LLC, Genentech, Inc
3/21/25 → 12/1/30
Project: Research project
-
Prot #TAK01796: Characterization of Early Response to Vedolizumab and IL-23 Antagonists in Participants with Crohn’s Disease Using Patient-Reported Outcome Measures (VOICE): A Prospective Observational Study
Dulai, P. S. (PD/PI)
Robarts Clinical Trials Inc, Takeda Development Center Americas, Inc.
3/20/25 → 3/20/28
Project: Research project
-
Pandolfino Chart Styring
Pandolfino, J. E. (PD/PI), Carlson, D. A. (Co-Investigator), Hungness, E. (Co-Investigator), Kou, W. (Co-Investigator) & Schauer, J. M. (Co-Investigator)
National Institute of Diabetes and Digestive and Kidney Diseases
1/20/25 → 11/30/28
Project: Research project
-
Prot #ABX464-107: A Randomized, Double-Blind, Multicenter Phase III Study to Evaluate the Long-Term Efficacy and Safety of ABX464 25 mg or 50 mg Once Daily as a Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis – ABTEC
Hanauer, S. B. (PD/PI)
12/18/24 → 12/18/27
Project: Research project
-
Prot #ABX464-105: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects with Moderately to Severely Active Ulcerative Colitis (ABTECT-1)
Hanauer, S. B. (PD/PI)
11/19/24 → 11/19/27
Project: Research project
-
Evaluating equity in antibiotic stewardship and disparities in appropriateness of antibiotic treatment
Evans, C. T. (PD/PI), Balbale, S. N. (Co-Investigator), Dhanani, M. (Co-Investigator) & Sutton, S. H. (Co-Investigator)
Agency for Healthcare Research and Quality
9/30/24 → 7/31/29
Project: Research project
-
Prot #LPS17558: A Phase 4, Randomized, Multicenter, Double-Blind, Parallel-Group, 24 Weeks, Placebo-Controlled Study Followed by 104 Weeks Open-Label to Assess Dupilumab Efficacy on Esophageal Function and Remodeling in Adult Participants with Eosinophili
Gonsalves, N. P. (PD/PI)
ICON Clinical Research, LLC, Sanofi US Services Inc.
9/26/24 → 9/26/27
Project: Research project
-
Project 2
Avella Patino, D. M. (Co-Investigator), Pandolfino, J. E. (Co-Investigator) & Perlman, H. R. (Other)
National Heart, Lung, and Blood Institute
9/17/24 → 7/31/29
Project: Research project
-
VA IPA for Richard Green
Pandolfino, J. E. (PD/PI) & Green, R. (Co-PD/PI)
Southern Arizona VA Health Care System
9/16/24 → 9/15/25
Project: Research project
-
(RFA) STING suppresses colitis through regulation of intestinal barrier function
Yang, W. (PD/PI) & Cong, Y. (Other)
Crohn's and Colitis Foundation of America
9/1/24 → 8/31/27
Project: Research project
-
A Pilot Assessment of Sleep and Circadian Rest-Activity Rhythms in IBD Patients
Summa, K. C. (PD/PI)
Northwestern Memorial Hospital
9/1/24 → 8/31/26
Project: Research project
-
Evolution of the Chicago Classification: Bridging Physiology and Mechanics
Carlson, D. A. (PD/PI), Pandolfino, J. E. (PD/PI), Kou, W. (Co-Investigator), Patankar, N. A. (Co-Investigator) & Schauer, J. M. (Co-Investigator)
National Institute of Diabetes and Digestive and Kidney Diseases
8/15/24 → 6/30/28
Project: Research project
-
Prot #R668-EGE-2213: A Phase 2/3, Randomized, 3-part Study to Investigate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients with Eosinophilic Gastritis with or without Eosinophilic Duodenitis
Gonsalves, N. P. (PD/PI)
ICON Clinical Research Limited, Regeneron Pharmaceuticals, Inc.
8/2/24 → 8/2/27
Project: Research project
-
Investigating the Molecular Mechanisms of Basal Cell Hyperplasia Persistence After Treatment in Eosinophilic Esophagitis
Tetreault, M.-P. (PD/PI), Carlson, D. A. (Other) & Gonsalves, N. P. (Other)
American Partnership for Eosinophilic Disorders
8/1/24 → 7/31/26
Project: Research project
-
Impact of Computer Aided Detection on Trainee Polyp Miss Rate Using A Tandem Colonoscopy Design
Keswani, R. N. (PD/PI)
5/23/24 → 11/23/26
Project: Research project
-
STING signaling in T cells regulation of intestinal homeostasis and inflammatorybowel diseases
Cong, Y. (PD/PI), Cong, Y. (PD/PI), Yang, W. (Other), Yang, W. (Other), Yao, S. (Other), Yao, S. (Other), Yu, T. (Other) & Yu, T. (Other)
National Institute of Diabetes and Digestive and Kidney Diseases
5/1/24 → 4/30/26
Project: Research project
-
The Neu-Lung Consortium: Neutrophilic Mechanisms of Inflammation, Injury, and Repair in Lung and Airways Diseases
Misharin, A. (Co-PD/PI), Abdala-Valencia, H. (Co-Investigator), Dulai, P. S. (Other) & Robinson, A. (Other)
National Institute of Allergy and Infectious Diseases
4/1/24 → 3/31/29
Project: Research project
-
Colonoscopy versus Stool-based Testing for Older Adults with a History of Colon Polyps (COOP)
Keswani, R. N. (PD/PI)
Dartmouth-Hitchcock Medical Center, Patient-Centered Outcomes Research Institute
4/1/24 → 9/30/29
Project: Research project
-
Prot #12.06.2022: Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples for the Non-Endoscopic Detection of Barrett’s Esophagus with and without Dysplasia
Komanduri, S. (PD/PI)
Mayo Clinic, EXACT Sciences Corporation
3/28/24 → 3/28/27
Project: Research project
-
Prot #Vedolizumab-4052: Re-define the IBD disease burden status
Dulai, P. S. (PD/PI) & Mao, C. (Co-Investigator)
Takeda Pharmaceuticals U.S.A., Inc.
3/11/24 → 3/11/27
Project: Research project
-
Gut microbiota metabolite sensing licenses IEC to cross talk with T cells to inhibit intestinal inflammation
Cong, Y. (PD/PI), Yang, W. (Other), Yao, S. (Other) & Yu, T. (Other)
National Institute of Diabetes and Digestive and Kidney Diseases
3/1/24 → 1/31/27
Project: Research project
-
CEGIR - OATFEED
Gonsalves, N. P. (PD/PI), Gonsalves, N. P. (PD/PI), Hirano, I. (Co-Investigator) & Hirano, I. (Co-Investigator)
Cincinnati Children's Hospital Medical Center
1/22/24 → 8/31/25
Project: Research project
-
Prot #1425-0003: A Phase IIa, Randomised, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of BI 706321 Orally Administered for 12 Weeks in Patients with Crohn`s Disease (CD) Receiving Ustekinu
Hanauer, S. B. (PD/PI)
Quintiles, Inc., Boehringer Ingelheim Pharmaceuticals, Inc.
1/17/24 → 1/17/27
Project: Research project